???global.info.a_carregar???
Ricardo Ribeiro, completed the PhD in Biomedical Sciences in 2012/05/17 at Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Mestrado in Ciencias do desporto in 1999/02/05 by Universidade do Porto Faculdade de Desporto, Licenciate in Physical Education and Sport in 1996/06/24 by University of Maia and Licenciate in Medicine in 2007/06/18 by University of Porto Institute of Biomedical Sciences Abel Salazar. Is Investigador in University of Porto at the Instituto de Investigação e Inovação em Saúde and MD at Centro Hospitalar Universitário do Porto. Published over 50 articles in peer-reviewed indexed journals. Has received 23 awards and/or honors. Participates and/or participated as Principal investigator in 2 project(s) and Researcher in 1 project(s). Works in the area(s) of Medical and Health Sciences with emphasis on Clinical Medicine and Medical and Health Sciences with emphasis on Basic Medicine with emphasis on Pathology. In his curriculum Ciência Vitae the most frequent terms in the context of scientific, technological and artistic-cultural output are: renal carcinoma; adipose tissue; immunometabolism; Hodgkin lymphoma; adipocytes; bone marrow; pharmacogenomics; prostate cancer; metastasis; CTCs; glycosylation; microfluidics; cancer; liquid biopsy; lab on a chip; hypertension; centenarians; genetics; longevity; colorectal cancer; tumor immunomodulation; tumor-associated macrophages; macrophage polarization; Toll-like receptor 9; genetic polymorphism; DNA methylation; Obesity; microenvironment; leptin; obesity; lung cancer; renin-angiotensin axis; Laboratory Medicine; Genetics; Pharmacogenetics; Liquid biopsy; immunology; medical microbiology; clinical chemistry ; hematopathology.
Ler resumo completo ↓
Identificação

Identificação pessoal

Nome completo
Ricardo Jorge Teixeira Ribeiro

Nomes de citação

  • Ribeiro, Ricardo

Identificadores de autor

Ciência ID
8612-04D5-18B9
ORCID iD
0000-0001-9785-857X

Endereços de correio eletrónico

  • ricardo.ribeiro@i3s.up.pt (Profissional)
  • ricardoribeiro.sqc@chporto.min-saude.pt (Profissional)

Moradas

  • Tumor and Microenvironment Interactions Group, i3S - Instituto de Investigação e Inovação em Saúde da Universidade do Porto. Rua Alfredo Allen, 208 , 4200-135, Porto, Porto, Portugal (Profissional)

Websites

Domínios de atuação

  • Ciências Médicas e da Saúde - Medicina Clínica
  • Ciências Médicas e da Saúde - Medicina Básica - Patologia

Idiomas

Idioma Conversação Leitura Escrita Compreensão Peer-review
Inglês Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1)
Francês Utilizador independente (B1) Utilizador proficiente (C1) Utilizador independente (B1) Utilizador independente (B1)
Espanhol; Castelhano Utilizador independente (B1) Utilizador proficiente (C1) Utilizador elementar (A1) Utilizador independente (B1)
Português Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1)
Formação
Grau Classificação
2021/04/26
Concluído
 Especialista em Patologia Clínica (Título de especialista)
Centro Hospitalar e Universitario de Coimbra EPE Campus dos Hospitais da Universidade de Coimbra, Portugal
 19.58/20
2012/05/17
Concluído
 Biomedical Sciences (Doutoramento)
Especialização em Molecular Oncology
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
"Obesity and prostate cancer: Epidemiology, genetics and molecular and cellular mechanisms" (TESE/DISSERTAÇÃO)
 Unanimously approved, with distinction and honor
2007/06/18
Concluído
 Medicine (Licenciatura)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
"n/a" (TESE/DISSERTAÇÃO)
 14/20
1999/02/05
Concluído
 Sport Sciences (Mestrado)
Especialização em High Performance Training
Universidade do Porto Faculdade de Desporto, Portugal
"Oral Creatine Supplementation - Biochemical Adaptations in Skeletal Muscle and Heaptic Tissue in Mice" (TESE/DISSERTAÇÃO)
 Very Good, Unanimously
1996/06/24
Concluído
 Physical Education and Sports (Licenciatura)
Especialização em Football - training
Instituto Universitário da Maia, Portugal
"Effects of oral creatine supplementation in basketball players" (TESE/DISSERTAÇÃO)
 17/20
Percurso profissional

Ciência

Categoria Profissional
Instituição de acolhimento 		Empregador
2017/01/01 - Atual Investigador (Investigação) Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2016/06/01 - 2022/01/01 Investigador (Investigação) Universidade de Lisboa Instituto de Saúde Ambiental, Portugal
Universidade de Lisboa Instituto de Saúde Ambiental, Portugal
2013/01 - 2013/06 Investigador visitante (Investigação) Instituto Nacional de Engenharia Biomédica, Portugal
Instituto Nacional de Engenharia Biomédica, Portugal
2010/10/01 - 2010/12/21 Investigador visitante (Investigação) McGill University Department of Oncology, Canadá
2010/06/01 - 2010/09/01 Investigador visitante (Investigação) Universidad de Navarra Facultad de Medicina, Espanha
2008/11/03 - 2008/12/20 Investigador visitante (Investigação) Universidad de Navarra Facultad de Medicina, Espanha

Docência no Ensino Superior

Categoria Profissional
Instituição de acolhimento 		Empregador
2023/09/01 - Atual Professor Associado (Docente Universitário) Universidade Fernando Pessoa, Portugal
Hospital-Escola da Universidade Fernando Pessoa, Portugal
2023/04/01 - Atual Professor Auxiliar Convidado (Docente Universitário) Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2015/01/01 - Atual Professor Auxiliar Convidado (Docente Universitário) Instituto Universitário da Maia, Portugal
Instituto Universitário da Maia, Portugal
2012/12/01 - 2022/12/31 Professor Auxiliar Convidado (Docente Universitário) Universidade de Lisboa Faculdade de Medicina, Portugal
Universidade de Lisboa Faculdade de Medicina, Portugal
2014/02/01 - 2016/07/15 Professor Visitante (Docente Universitário) Instituto Universitário da Maia, Portugal
2010/03/01 - 2010/03/30 Leitor (Docente Universitário) Universidade de Trás-os-Montes e Alto Douro Escola de Ciências e Tecnologia, Portugal
2008/01/01 - 2010/03/30 Monitor (Docente Universitário) Universidade do Porto Faculdade de Medicina, Portugal
2008/01/01 - 2009/12/30 Leitor (Docente Universitário) Universidade do Porto Faculdade de Medicina, Portugal
2009/01/01 - 2009/01/30 Leitor (Docente Universitário) Universidade Católica Portuguesa Instituto de Ciências da Saúde Porto, Portugal
2008/05/01 - 2008/05/30 Leitor (Docente Universitário) Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal

Outros

Categoria Profissional
Instituição de acolhimento 		Empregador
2021/09/01 - Atual Medical Doctor Centro Hospitalar Universitário do Porto EPE, Portugal
Centro Hospitalar Universitário do Porto EPE, Portugal
2017/01/01 - 2021/04/26 Medical Doctor Centro Hospitalar e Universitário de Coimbra EPE, Portugal
Centro Hospitalar e Universitário de Coimbra EPE, Portugal
2016/01/01 - 2016/12/31 Medical Doctor Centro Hospitalar de Trás-os-montes e Alto Douro EPE, Portugal
Centro Hospitalar de Trás-os-montes e Alto Douro EPE, Portugal
2014/01/01 - 2016/08/01 Researcher Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
2007 - 2012/04/01 PhD Researcher Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
2003/02/03 - 2006/03/01 Voluntary Junior Researcher Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
2002/06/01 - 2002/09/18 Voluntary Junior Researcher; Reabilitação Cardíaca Centro Hospitalar Universitário do Porto EPE, Portugal
1997/10/01 - 1998/03/01 MSc Researcher, Biochemistry of Exercise Laboratory and Physiology Laboratory Universidade do Porto Faculdade de Desporto, Portugal
Projetos

Bolsa

Designação Financiadores
2021/02/05 - Atual Identification of EVs-derived miRNAs as non-invasive high-risk BlCa biomarkers
EXOmiRsBlCaMark
Investigador responsável
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
 Porto Comprehensive Cancer Centre
Em curso
2021/01/01 - Atual Spatial transcriptomics to uncover the impact of perinodal adipose tissue in Hodgkin Lymphoma
NoCoDE
Investigador responsável
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
Em curso
2020/06/04 - 2022/02/05 Targeting Immunometabolism on Clear Cell Renal Cancer
ID 2019-09-2475
Investigador responsável
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal

Instituto Nacional de Engenharia Biomédica, Portugal
Bayer Pharma AG Forschung und Entwicklung
Concluído
2009/11/01 - 2014/03/31 Molecular mechanisms of adiponectin and therapeutic potential in prostate cancer: in vitro studies with recombinant adiponectin
CIMAGO 07/09
Investigador responsável
Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
 Associação de Apoio ao Centro de Investigação em Meio Ambiente Genética e Oncobiologia

Porto Comprehensive Cancer Centre
Concluído

Projeto

Designação Financiadores
2020/06/30 - 2021/01/08 Serological and cytokine profiling to evaluate SAR-CoV-2 exposure
RESEARCH4COVID 19, refNo. 460
Investigador
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
 Associação para a Inovação e Desenvolvimento da FCT
Concluído
2007/07 - 2010/12 Bone Turnover Associated-Pharmacogenomic Profile of Patients with Metastatic and Non-Metastatic Prostate Cancer: Predictive Factors for the Benefits of Bisphosphonate Treatment?
PTDC/SAU-FCF/71552/2006
Investigador
Instituto Português de Oncologia do Porto Francisco Gentil Centro de Investigação, Portugal
 Fundação para a Ciência e a Tecnologia, I.P.
Concluído
Produções

Publicações

Artigo em revista
  1. Campos, Rui; Shanmugam, Saranya Thiruvottriyur; Daems, Elise; Ribeiro, Ricardo; De Wael, Karolien. "Development of an electrochemiluminescent oligonucleotide-based assay for the quantification of prostate cancer associated miR-141-3p in human serum". Bioelectrochemistry 153 (2023): 108495. http://dx.doi.org/10.1016/j.bioelechem.2023.108495.
    10.1016/j.bioelechem.2023.108495
  2. Fonseca, Jorge; Froes, Gonçalo; Moraes-Fontes, Maria Francisca; Rebola, Jorge; Lúcio, Rui; Almeida, Miguel; Muresan, Ciprian; et al. "Urinary continence recovery after Retzius-sparing robot-assisted radical prostatectomy in relation to surgeon experience". Journal of Robotic Surgery 17 5 (2023): 2503-2511. http://dx.doi.org/10.1007/s11701-023-01687-8.
    10.1007/s11701-023-01687-8
  3. Fonseca, Jorge; Moraes-Fontes, Maria Francisca; Rebola, Jorge; Lúcio, Rui; Almeida, Miguel; Muresan, Ciprian; Palmas, Artur; et al. "Retzius-sparing robot-assisted radical prostatectomy in a medium size oncological center holds adequate oncological and functional outcomes". Journal of Robotic Surgery 17 3 (2023): 1133-1142. http://dx.doi.org/10.1007/s11701-022-01517-3.
    10.1007/s11701-022-01517-3
  4. Preza-Fernandes, José; Passos, Pedro; Mendes-Ferreira, Miguel; Rodrigues, Adriana R.; Gouveia, Alexandra; Fraga, Avelino; Medeiros, Rui; Ribeiro, Ricardo. "A hint for the obesity paradox and the link between obesity, perirenal adipose tissue and Renal Cell Carcinoma progression". Scientific Reports 12 1 (2022): http://dx.doi.org/10.1038/s41598-022-24418-9.
    10.1038/s41598-022-24418-9
  5. Joana Oliveira-Silva; Teresa Reis; Cristiana Lopes; Ricardo Batista-Silva; Ricardo Ribeiro; Gilberto Marques; Vania Pacheco; et al. "Long-term serological SARS-CoV-2 IgG kinetics following mRNA COVID-19 vaccine: real-world data from a large cohort of healthcare workers". International Journal of Infectious Diseases (2022): https://doi.org/10.1016/j.ijid.2022.05.026.
    10.1016/j.ijid.2022.05.026
  6. Liu, Qian; Reed, Madison; Zhu, Haiying; Cheng, Yan; Almeida, Joana; Fruhbeck, Gema; Ribeiro, Ricardo; Hu, Pingzhao. "Epigenome-wide DNA methylation and transcriptome profiling of localized and locally advanced prostate cancer: Uncovering new molecular markers". Genomics 114 5 (2022): 110474. http://dx.doi.org/10.1016/j.ygeno.2022.110474.
    10.1016/j.ygeno.2022.110474
  7. Matos, Andreia; Carvalho, Marcos; Bicho, Manuel; Ribeiro, Ricardo. "Arginine and Arginases Modulate Metabolism, Tumor Microenvironment and Prostate Cancer Progression". Nutrients 13 12 (2021): 4503. http://dx.doi.org/10.3390/nu13124503.
    10.3390/nu13124503
  8. Oliveira-Silva, Joana; Reis, Teresa; Lopes, Cristiana; Batista-Silva, Ricardo; Ribeiro, Ricardo; Marques, Gilberto; Pacheco, Vânia; et al. "Humoral response to the SARS-CoV-2 BNT162b2 mRNA vaccine: Real-world data from a large cohort of healthcare workers". Vaccine (2021): http://dx.doi.org/10.1016/j.vaccine.2021.12.014.
    10.1016/j.vaccine.2021.12.014
  9. Rocha-Rodrigues, Sílvia; Matos, Andreia; Afonso, José; Mendes-Ferreira, Miguel; Abade, Eduardo; Teixeira, Eduardo; Silva, Bruno; et al. "Skeletal Muscle–Adipose Tissue–Tumor Axis: Molecular Mechanisms Linking Exercise Training in Prostate Cancer". International Journal of Molecular Sciences 22 9 (2021): 4469. http://dx.doi.org/10.3390/ijms22094469.
    10.3390/ijms22094469
  10. Catarata, Maria Joana; Lourenço, Margarida; Martins, Maria Fátima; Frade, João; Pêgo, Alice; Cordeiro, Carlos Robalo; Medeiros, Rui; Ribeiro, Ricardo. "Pharmacogenetics of advanced lung cancer: Predictive value of functional genetic polymorphism AGXT Pro11Leu in clinical outcome?". Pulmonology 27 2 (2021): 116-123. http://dx.doi.org/10.1016/j.pulmoe.2020.11.007.
    10.1016/j.pulmoe.2020.11.007
  11. Ribeiro, Ricardo. "IL-2 and IFN-¿ are biomarkers of SARS-CoV-2 specific cellular response in whole blood stimulation assays". MedRxiv NA NA (2021): 1-30.
    Acesso aberto • 10.1101/2021.01.04.20248897
  12. Maria Joana Catarata; r medeiros; MJ Oliveira, Maria J Oliveira, M J Oliveira; Alice Pêgo; João Gonçalo Frade; Maria Fátima Martins; Carlos Robalo Cordeiro; et al. "Germline Genetic Variants of the Renin-Angiotensin System, Hypoxia and Angiogenesis in Non-Small Cell Lung Cancer Progression: Discovery and Validation Studies". Cancers (2020): https://www.mdpi.com/2072-6694/12/12/3834.
    10.3390/cancers12123834
  13. Ribeiro, Ricardo. "Phenotypic Analysis of Urothelial Exfoliated Cells in Bladder Cancer via Microfluidic Immunoassays: Sialyl-Tn as a Novel Biomarker in Liquid Biopsies". Frontiers in Oncology 10 (2020): http://dx.doi.org/10.3389/fonc.2020.01774.
    10.3389/fonc.2020.01774
  14. Catarata, Maria Joana; Ribeiro, Ricardo; Oliveira, Maria José; Robalo Cordeiro, Carlos; Medeiros, Rui. "Renin-Angiotensin System in Lung Tumor and Microenvironment Interactions". Cancers 12 6 (2020): 1457. http://dx.doi.org/10.3390/cancers12061457.
    10.3390/cancers12061457
  15. Oliveira, Manuel Castanheira de; Caires, Hugo R.; Oliveira, Maria J.; Fraga, Avelino; Vasconcelos, M. Helena; Ribeiro, Ricardo. "Urinary Biomarkers in Bladder Cancer: Where Do We Stand and Potential Role of Extracellular Vesicles". Cancers 12 6 (2020): 1400. http://dx.doi.org/10.3390/cancers12061400.
    10.3390/cancers12061400
  16. Pinto, Marta L.; Rios, Elisabete; Durães, Cecília; Ribeiro, Ricardo; Machado, José C.; Mantovani, Alberto; Barbosa, Mário A.; Carneiro, Fatima; Oliveira, Maria J.. "The Two Faces of Tumor-Associated Macrophages and Their Clinical Significance in Colorectal Cancer". Frontiers in Immunology 10 (2019): http://dx.doi.org/10.3389/fimmu.2019.01875.
    Acesso aberto • 10.3389/fimmu.2019.01875
  17. Gonçalves-Anjo, Nuno; Leite-Pinheiro, Fátima; Ribeiro, Ricardo; Requicha, João Filipe; Lourenço, Ana Luísa; Dias, Isabel; Viegas, Carlos; Bastos, Estela. "Toll-like receptor 9 gene in Periodontal Disease – A promising biomarker". Gene 687 (2019): 207-211. http://dx.doi.org/10.1016/j.gene.2018.11.060.
    Publicado • 10.1016/j.gene.2018.11.060
  18. Neves, Manuel; Azevedo, Rita; Lima, Luís; Oliveira, Marta I.; Peixoto, Andreia; Ferreira, Dylan; Soares, Janine; et al. "Exploring sialyl-Tn expression in microfluidic-isolated circulating tumour cells: A novel biomarker and an analytical tool for precision oncology applications". New Biotechnology 49 (2019): 77-87. http://dx.doi.org/10.1016/j.nbt.2018.09.004.
    Publicado • 10.1016/j.nbt.2018.09.004
  19. Pereira da Silva, Alda; Matos, Andreia; Aguiar, Laura; Ramos-Marques, Nuno; Ribeiro, Ricardo; Gil, Ângela; Gorjão-Clara, João; Bicho, Manuel. "Hypertension and longevity: role of genetic polymorphisms in renin-angiotensin-aldosterone system and endothelial nitric oxide synthase". Molecular and Cellular Biochemistry 455 1-2 (2018): 61-71. http://dx.doi.org/10.1007/s11010-018-3470-1.
    Publicado • 10.1007/s11010-018-3470-1
  20. Cheng, Yan; Monteiro, Cátia; Matos, Andreia; You, Jiaying; Fraga, Avelino; Pereira, Carina; Catalán, Victoria; et al. "Epigenome-wide DNA methylation profiling of periprostatic adipose tissue in prostate cancer patients with excess adiposity—a pilot study". Clinical Epigenetics 10 1 (2018): 54. http://dx.doi.org/10.1186/s13148-018-0490-3.
    Publicado • 10.1186/s13148-018-0490-3
  21. Ribeiro, Ricardo. "Mountain Cycling Ultramarathon Effects on Inflammatory and Hemoglobin Responses.". Medicine and science in sports and exercise (2018): https://doi.org/10.1249/MSS.0000000000001440.
    10.1249/mss.0000000000001440
  22. Da Silva, A.P.; Matos, A.; Ribeiro, R.; Gil, A.; Valente, A.; Bicho, M.; Gorjão-Clara, J.. "Sarcopenia and osteoporosis in Portuguese centenarians". European Journal of Clinical Nutrition 71 1 (2017): 56-63. http://www.scopus.com/inward/record.url?eid=2-s2.0-84988638037&partnerID=MN8TOARS.
    10.1038/ejcn.2016.174
  23. Fraga, A.; Ribeiro, R.; Coelho, A.; Vizcaíno, J.R.; Coutinho, H.; Lopes, J.M.; Príncipe, P.; et al. "Genetic polymorphisms in key hypoxia-regulated downstream molecules and phenotypic correlation in prostate cancer". BMC Urology 17 1 (2017): 1-12. http://www.scopus.com/inward/record.url?eid=2-s2.0-85011345078&partnerID=MN8TOARS.
    10.1186/s12894-017-0201-y
  24. Lima, L.; Neves, M.; Oliveira, M.I.; Dieguez, L.; Freitas, R.; Azevedo, R.; Gaiteiro, C.; et al. "Sialyl-Tn identifies muscle-invasive bladder cancer basal and luminal subtypes facing decreased survival, being expressed by circulating tumor cells and metastases". Urologic Oncology: Seminars and Original Investigations 35 12 (2017): 675.e1-675.e8. http://www.scopus.com/inward/record.url?eid=2-s2.0-85029177175&partnerID=MN8TOARS.
    10.1016/j.urolonc.2017.08.012
  25. Matos, A.; Marinho-Dias, J.; Ramalheira, S.; Oliveira, M.J.; Bicho, M.; Ribeiro, R.. "Mechanisms underlying the association between obesity and Hodgkin lymphoma". Tumor Biology 37 10 (2016): 13005-13016. http://www.scopus.com/inward/record.url?eid=2-s2.0-84980004903&partnerID=MN8TOARS.
    10.1007/s13277-016-5198-4
  26. Pereira da Silva, A.; Matos, A.; Valente, A.; Gil, Â.; Alonso, I.; Ribeiro, R.; Bicho, M.; Gorjão-Clara, J.. "Body composition assessment and nutritional status evaluation in men and women Portuguese centenarians". Journal of Nutrition, Health and Aging 20 3 (2016): 256-266. http://www.scopus.com/inward/record.url?eid=2-s2.0-84959538848&partnerID=MN8TOARS.
    10.1007/s12603-015-0566-0
  27. Fraga, A.; Ribeiro, R.; Príncipe, P.; Lopes, C.; Medeiros, R.. "Hypoxia and Prostate Cancer Aggressiveness: A Tale with Many Endings". Clinical Genitourinary Cancer 13 4 (2015): 295-301. http://www.scopus.com/inward/record.url?eid=2-s2.0-84936985434&partnerID=MN8TOARS.
    10.1016/j.clgc.2015.03.006
  28. Ribeiro, R.. "Obesity and genitourinary cancer risks". Journal of Urology 192 4 (2014): 1015-1016. http://www.scopus.com/inward/record.url?eid=2-s2.0-84921964289&partnerID=MN8TOARS.
    10.1016/j.juro.2014.07.080
  29. Fraga, A.; Ribeiro, R.; Príncipe, P.; Lobato, C.; Pina, F.; Maurício, J.; Monteiro, C.; et al. "The HIF1A functional genetic polymorphism at locus +1772 associates with progression to metastatic prostate cancer and refractoriness to hormonal castration". European Journal of Cancer (2013): http://www.scopus.com/inward/record.url?eid=2-s2.0-84884695463&partnerID=MN8TOARS.
    10.1016/j.ejca.2013.09.001
  30. Monteiro, C.; Sousa, M.V.; Ribeiro, R.; Maurício, J.; Fraga, A.; Medeiros, R.. "Genetic variants in AR and SHBG and resistance to hormonal castration in prostate cancer". Medical Oncology 30 1 (2013): http://www.scopus.com/inward/record.url?eid=2-s2.0-84873349067&partnerID=MN8TOARS.
    10.1007/s12032-013-0490-2
  31. Magalhães, J.F.; Cortinhas, A.J.; Albuquerque, C.M.; Baptista, C.S.; Ribeiro, R.; Viegas, C.; Matos, A.; et al. "Interleukin-6 gene -174G>C and -636G>C promoter polymorphisms and prostate cancer risk". Molecular Biology Reports 40 1 (2013): 449-455. http://www.scopus.com/inward/record.url?eid=2-s2.0-84871289888&partnerID=MN8TOARS.
    10.1007/s11033-012-2079-9
  32. Ribeiro, R.; Monteiro, C.; Silvestre, R.; Castela, A.; Coutinho, H.; Fraga, A.; Príncipe, P.; et al. "Human periprostatic white adipose tissue is rich in stromal progenitor cells and a potential source of prostate tumor stroma". Experimental Biology and Medicine 237 10 (2012): 1155-1162. http://www.scopus.com/inward/record.url?eid=2-s2.0-84868224535&partnerID=MN8TOARS.
    10.1258/ebm.2012.012131
  33. Ribeiro, R.; Monteiro, C.; Catalán, V.; Hu, P.; Cunha, V.; Rodríguez, A.; Gómez-Ambrosi, J.; et al. "Obesity and prostate cancer: Gene expression signature of human periprostatic adipose tissue". BMC Medicine 10 (2012): http://www.scopus.com/inward/record.url?eid=2-s2.0-84866532210&partnerID=MN8TOARS.
    10.1186/1741-7015-10-108
  34. Ribeiro, R.; Monteiro, C.; Cunha, V.; Oliveira, M.; Freitas, M.; Fraga, A.; Príncipe, P.; et al. "Human periprostatic adipose tissue promotes prostate cancer aggressiveness in vitro". Journal of Experimental and Clinical Cancer Research 31 1 (2012): http://www.scopus.com/inward/record.url?eid=2-s2.0-85027938362&partnerID=MN8TOARS.
    10.1186/1756-9966-31-3222469146
  35. Ribeiro, R.J.T.; Monteiro, C.P.D.; Azevedo, A.S.M.; Cunha, V.F.M.; Ramanakumar, A.V.; Fraga, A.M.; Pina, F.M.; et al. "Performance of an adipokine pathway-based multilocus genetic risk score for prostate cancer risk prediction". PLoS ONE 7 6 (2012): http://www.scopus.com/inward/record.url?eid=2-s2.0-84863092426&partnerID=MN8TOARS.
    10.1371/journal.pone.0039236
  36. Araújo, A.P.; Catarino, R.; Ribeiro, R.; Pereira, D.; Pinto, D.; Medeiros, R.. "Epidermal growth factor genetic variation associated with advanced cervical cancer in younger women". American Journal of Clinical Oncology: Cancer Clinical Trials 35 3 (2012): 247-250. http://www.scopus.com/inward/record.url?eid=2-s2.0-84861529358&partnerID=MN8TOARS.
    10.1097/COC.0b013e31820dbbf5
  37. Ribeiro, R.J.T.; Monteiro, C.P.D.; Cunha, V.F.P.M.; Azevedo, A.S.M.; Oliveira, M.J.; Monteiro, R.; Fraga, A.M.; et al. "Tumor cell-educated periprostatic adipose tissue acquires an aggressive cancer-promoting secretory profile". Cellular Physiology and Biochemistry 29 1-2 (2012): 233-240. http://www.scopus.com/inward/record.url?eid=2-s2.0-84859829669&partnerID=MN8TOARS.
    10.1159/000337604
  38. Ribeiro, R.; Monteiro, C.; Cunha, V.; Oliveira, M.J.; Freitas, M.; Fraga, A.; Principe, P.; et al. "Human periprostatic adipose tissue promotes prostate cancer aggressiveness in vitro". Journal of Experimental & Clinical Cancer Research (2012): http://www.scopus.com/inward/record.url?eid=2-s2.0-84859123337&partnerID=MN8TOARS.
    10.1186/1756-9966-31-32
  39. Botelho, M.C.; Ribeiro, R.; Vale, N.; Oliveira, P.; Medeiros, R.; Lopes, C.; Machado, J.C.; Correia Da Costa, J.M.. "Inactivation of estrogen receptor by Schistosoma haematobium total antigen in bladder urothelial cells". Oncology Reports 27 2 (2012): 356-362. http://www.scopus.com/inward/record.url?eid=2-s2.0-84855754142&partnerID=MN8TOARS.
    10.3892/or.2011.1552
  40. Castela, Â.; Soares, R.; Rocha, F.; Medeiros, R.; Ribeiro, R.; Monteiro, C.; Gomes, P.; et al. "Differentially expressed angiogenic genes in diabetic erectile tissue - Results from a microarray screening". Molecular Genetics and Metabolism 105 2 (2012): 255-262. http://www.scopus.com/inward/record.url?eid=2-s2.0-84856080147&partnerID=MN8TOARS.
    10.1016/j.ymgme.2011.11.002
  41. Fontenete, S.; Silva, J.; Teixeira, A.L.; Ribeiro, R.; Bastos, E.; Pina, F.; Medeiros, R.. "Controversies in using urine samples for Prostate Cancer detection: PSA and PCA3 expression analysis". International Braz J Urol 37 6 (2011): 719-726. http://www.scopus.com/inward/record.url?eid=2-s2.0-84861008474&partnerID=MN8TOARS.
    10.1590/S1677-55382011000600006
  42. Teixeira, A.L.; Araújo, A.; Coelho, A.; Ribeiro, R.; Gomes, M.; Pereira, C.; Medeiros, R.. "Influence of TGFB1+869T>C functional polymorphism in non-small cell lung cancer (NSCLC) risk". Journal of Cancer Research and Clinical Oncology 137 3 (2011): 435-439. http://www.scopus.com/inward/record.url?eid=2-s2.0-79954437963&partnerID=MN8TOARS.
    10.1007/s00432-010-0896-6
  43. Botelho, M.C.; Soares, R.; Vale, N.; Ribeiro, R.; Camilo, V.; Almeida, R.; Medeiros, R.; et al. "Schistosoma haematobium: Identification of new estrogenic molecules with estradiol antagonistic activity and ability to inactivate estrogen receptor in mammalian cells". Experimental Parasitology 126 4 (2010): 526-535. http://www.scopus.com/inward/record.url?eid=2-s2.0-79960934913&partnerID=MN8TOARS.
    10.1016/j.exppara.2010.06.012
  44. Fraga, A.; Ribeiro, R.; Medeiros, R.. "Tumor hypoxia: The role of HIF | Hipoxia tumoral. Papel del factor inducible por hipoxia". Actas Urologicas Espanolas 33 9 (2009): 941-951. http://www.scopus.com/inward/record.url?eid=2-s2.0-75649133242&partnerID=MN8TOARS.
    10.1016/S0210-4806(09)72891-8
  45. Teixeira, A.L.; Ribeiro, R.; Morais, A.; Lobo, F.; Fraga, A.; Pina, F.; Calais-da-Silva, F.M.; Calais-da-Silva, F.E.; Medeiros, R.. "Combined analysis of EGF+61G>A and TGFB1+869T>C functional polymorphisms in the time to androgen independence and prostate cancer susceptibility". Pharmacogenomics Journal 9 5 (2009): 341-346. http://www.scopus.com/inward/record.url?eid=2-s2.0-70349694553&partnerID=MN8TOARS.
    10.1038/tpj.2009.20
  46. Araüjo, A.P.; Ribeiro, R.; Pinto, D.; Pereira, D.; Sousa, B.; Mauricio, J.; Lopes, C.; Medeiros, R.. "Epidermal growth factor genetic variation, breast cancer risk, and waiting time to onset of disease". DNA and Cell Biology 28 5 (2009): 265-269. http://www.scopus.com/inward/record.url?eid=2-s2.0-65549171488&partnerID=MN8TOARS.
    10.1089/dna.2008.0823
  47. Araújo, A.P.; Ribeiro, R.; Pereira, D.; Pinto, D.; Sousa, B.; Catarino, R.; Medeiros, R.. "Ovarian cancer and genetic susceptibility: Association of A61G polymorphism in the EGF gene". Experimental Biology and Medicine 234 3 (2009): 241-245. http://www.scopus.com/inward/record.url?eid=2-s2.0-63349107870&partnerID=MN8TOARS.
    10.3181/0805-RM-146
  48. Teixeira, A.L.; Ribeiro, R.; Cardoso, D.; Pinto, D.; Lobo, F.; Fraga, A.; Pina, F.; Calais-da-Silva, F.; Medeiros, R.. "Genetic polymorphism in EGF Is associated with prostate cancer aggressiveness and progression-free interval in androgen blockade-treated patients". Clinical Cancer Research 14 11 (2008): 3367-3371. http://www.scopus.com/inward/record.url?eid=2-s2.0-50349084344&partnerID=MN8TOARS.
    10.1158/1078-0432.CCR-07-5119
  49. Ribeiro, R.; Soares, Â.; Pinto, D.; Catarino, R.; Lopes, C.; Medeiros, R.. "EGF genetic polymorphism is associated with clinical features but not malignant phenotype in neurofibromatosis type 1 patients". Journal of Neuro-Oncology 81 3 (2007): 225-229. http://www.scopus.com/inward/record.url?eid=2-s2.0-33846553750&partnerID=MN8TOARS.
    10.1007/s11060-006-9224-z
  50. Ribeiro, R.; Araújo, A.; Lopes, C.; Medeiros, R.. "Immunoinflammatory mechanisms in lung cancer development: Is leptin a mediator?". Journal of Thoracic Oncology 2 2 (2007): 105-108. http://www.scopus.com/inward/record.url?eid=2-s2.0-34247104585&partnerID=MN8TOARS.
    10.1016/S1556-0864(15)30035-6
  51. Araújo, A.; Ribeiro, R.; Azevedo, I.; Coelho, A.; Soares, M.; Sousa, B.; Pinto, D.; et al. "Genetic polymorphisms of the epidermal growth factor and related receptor in non-small cell lung cancer - A review of the literature". Oncologist 12 2 (2007): 201-210. http://www.scopus.com/inward/record.url?eid=2-s2.0-33847056277&partnerID=MN8TOARS.
    10.1634/theoncologist.12-2-201
  52. Ribeiro, R.; Araújo, A.P.; Coelho, A.; Catarino, R.; Pinto, D.; Araújo, A.; Calçada, C.; Lopes, C.; Medeiros, R.. "A functional polymorphism in the promoter region of leptin gene increases susceptibility for non-small cell lung cancer". European Journal of Cancer 42 8 (2006): 1188-1193. http://www.scopus.com/inward/record.url?eid=2-s2.0-33646414773&partnerID=MN8TOARS.
    10.1016/j.ejca.2006.02.004
  53. Ribeiro, R.; Lopes, C.; Medeiros, R.. "The link between obesity and prostate cancer: The leptin pathway and therapeutic perspectives". Prostate Cancer and Prostatic Diseases 9 1 (2006): 19-24. http://www.scopus.com/inward/record.url?eid=2-s2.0-33644887167&partnerID=MN8TOARS.
    10.1038/sj.pcan.4500844
  54. Ribeiro, Ricardo; Vasconcelos, Andr¿; Costa, Sandra; Pinto, Daniela; Morais, Antonio; Oliveira, Jorge; Lobo, Francisco; Lopes, Carlos; Medeiros, Rui. "Overexpressing leptin genetic polymorphism (?2548 G/A) is associated with susceptibility to prostate cancer and risk of advanced disease". The Prostate 59 3 (2004): 268-274. http://dx.doi.org/10.1002/pros.20004.
    Publicado • 10.1002/pros.20004
  55. Ribeiro, R.; Lopes, C.; Medeiros, R.. "Leptin and prostate: Implications for cancer prevention - Overview of genetics and molecular interactions". European Journal of Cancer Prevention 13 5 (2004): 359-368. http://www.scopus.com/inward/record.url?eid=2-s2.0-5044230358&partnerID=MN8TOARS.
    10.1097/00008469-200410000-00002
Capítulo de livro
  1. Moreira-Barbosa, Catarina; Matos, Andreia; Fernandes, Rui; Mendes-Ferreira, Miguel; Rodrigues, Rafaela; Cruz, Tânia; Costa, Ângela Margarida; et al. "The role of fatty acids metabolism on cancer progression and therapeutics development". In Bioactive Lipids, 101-132. Elsevier, 2023.
    10.1016/b978-0-12-824043-4.00007-5
Poster em conferência
  1. Ribeiro, Ricardo. "In silico analyses for subsequent genotyping and sequencing of DPYD gene in clinical pharmacogenetics.". Trabalho apresentado em XV Jornadas de Genética e Biotecnologia | V Jornadas Ibéricas de Genética y Biotecnología. UTAD, Vila Real, 22-23rd march 2023, 2023.
Resumo em conferência
  1. Ribeiro, Ricardo. "Adipocytes modulate immune populations at reactive inflammatory Hodgkin Tumour Microenvironment.". Trabalho apresentado em XLVIII Annual Meeting of the Portuguese Society for Immunology, Aveiro, 2023.
    Aceite para publicação
  2. Ribeiro, Ricardo. "Adipocytes from obese subjects modulate immune populations of the reactive inflammatory Hodgkin Tumour Microenvironment.". Trabalho apresentado em 46th ATDG: Adipose biology: Metabolic buffering in an obesigenic world. Danish Diabetes and Endocrine Academy, the Society for Endocrinology and the British Heart Foundation, , 23-24th March 2023., Edinburgh, 2023.
    Aceite para publicação
  3. Ribeiro, Ricardo. "In silico analyses for subsequent genotyping and sequencing tpmt and nudt15 genes in clinical pharmacogenetics.". Trabalho apresentado em XV Jornadas de Genética e Biotecnologia | V Jornadas Ibéricas de Genética y Biotecnología., Vila Real, 2023.
    Aceite para publicação
  4. Ribeiro, Ricardo. "Recapitulating the Tumor Microenvironment of Hodgkin Lymphoma disease: adipocytes are friends or foe?". Trabalho apresentado em 5th ASPIC International Congress. Portuguese Institute of Oncology, Porto, june 30th - july 1st 2022., Porto, 2022.
    Aceite para publicação
  5. Ribeiro, Ricardo. "The peritumoural adipose tissue and clear cell renal cell carcinoma interface: insights on the obesity paradox.". Trabalho apresentado em EMBO Practical Course - Single cell genomics: Get started! Braga, august 30th – september 5th 2021., Braga, 2021.
    Aceite para publicação
  6. Pereira Catarata, Maria Joana; Ribeiro, Ricardo; Pêgo, Alice; Robalo Cordeiro, Carlos; Oliveira, Maria José; Medeiros, Rui; Thomas, Michael; Meister, Michael; Muley, Thomas. "Genetic polymorphisms of renin-angiotensin system and angiogenic factors in NSCLC progression: discovery and validation studies". Trabalho apresentado em ERS International Congress 2020, Barcelona, 2020.
    Aceite para publicação • 10.1183/13993003.congress-2020.1756
  7. Pereira Catarata, Maria Joana; Ribeiro, Ricardo; Oliveira, Maria José; Thomas, Michael; Meister, Michael; Muley, Thomas. "Neprilysin functional genetic polymorphism in NSCLC progression without PD-L1 expression". Trabalho apresentado em ERS International Congress 2020, Barcelona, 2020.
    Publicado • 10.1183/13993003.congress-2020.1768
  8. Ribeiro, Ricardo. "Extracellular vesicles as a source of cancer biomarkers in the urine of urothelial carcinoma patients: characterization of a two-step protocol for urinary EV isolation.". Trabalho apresentado em ISEV2020 Annual Meeting, Virtual Conference, 2020.
    Aceite para publicação
  9. "APPLICATION AND VALIDATION OF AN EQUATION FOR ADJUSTMENT OF SERUM COPPER TO CERULOPLASMIN AND ITS CLINICAL APPLICABILITY TO WILSON DISEASE". Trabalho apresentado em 11th National Scientifc Congress SPML, Coimbra, 2020.
    Publicado • 10.1515/ cclm-2019-1173
  10. "Latex-enhanced immunoturbidimetric assay for procalcitonin: Methods comparison, analytical and clinical performance". Trabalho apresentado em EuroMedLab 2019, Barcelona, 2019.
    10.1016/j.cca.2019.03.074
  11. Pereira Catarata, M.J.; Ribeiro, R.; Robalo Cordeiro, C.. "Impact of Time Exposure to Renin-Angiotensin Blockers on Survival of Patients with Localized Non-Small Cell Lung Cancer". Trabalho apresentado em American Thoracic Society 2019 International Conference, Dallas, 2019.
    Publicado • 10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a7290
  12. Pereira Catarata, M.J.; Ribeiro, R.; Robalo Cordeiro, C.. "Impact of Time Exposure to Renin-Angiotensin Blockers on Survival of Patients with Localized Non-Small Cell Lung Cancer". 2019.
    10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a7290
  13. "Lymphotoxin alpha functional germline genetic variant: A future prognostic factor in colorectal cancer?". Trabalho apresentado em ESMO Immuno-Oncology Congress 2018, Geneva, 2018.
    Publicado • 10.1093/annonc/mdy493.024
  14. "Profiling macrophage populations in human colorectal cancer". Trabalho apresentado em 8th International Conference on Cancer Microenvironment, Lisbon, 2018.
    Publicado • 10.1007/s12307-018-0212-6
  15. Ribeiro, Ricardo. "Molecular targeting of obesity pathways in cancer". Trabalho apresentado em European Obesity Summit (EOS) - Joint Congress of EASOand IFSO-EC, Gothenburg, 2016.
    Publicado • 10.1159/000446744
  16. "Variation in TRMT11 gene as a prognostic marker in advanced-stage castrate-resistant prostate cancer (CRPC) patients.". Trabalho apresentado em 2015 ASCO Annual Meeting, Chicago, 2015.
    Publicado • 10.1200/jco.2015.33.15_suppl.e16114
  17. "HIF1a 1772C/T Polymorphism and Prognosis in Renal Cell Carcinoma". Trabalho apresentado em 2011 European Multidisciplinary Cancer Congress, Stockholm, 2011.
    Publicado • 10.1016/S0959-8049(11)72071-8
Tese / Dissertação
  1. "Obesity and prostate cancer: epidemiology, genetics and molecular and cellular mechanisms". Doutoramento, Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, 2012.

Propriedade Intelectual

Patente
  1. Ferreira, José Alexandre; Marta Oliveira; Diéguez, Lorena; Santos, Lúcio Lara; Celso Reis. 2018. "Detection and isolation of cancer cells from body fluids based on a glycosylation pattern and methods of use thereof". Portugal.
    Concedida/Emitida
Atividades

Apresentação oral de trabalho

Título da apresentação Nome do evento
Anfitrião (Local do evento)
2023/03/23 Invited speaker, Conference on Liquid Biopsy in Oncology. XV Jornadas de Genética e Biotecnologia | V Jornadas Ibéricas de Genética y Biotecnología. UTAD, Vila Real, march 23rd 2023.
Universidade de Tras os Montes e Alto Douro (Vila Real, Portugal)
2022/03/18 Liquid biopsy in oncology XI Congress of Clinical Pathology.
Sociedade Portuguesa de Patologia Clinica (Lisboa, Portugal)
2019/04/06 Application and validation of an equation for adjustment of serum copper to ceruloplasmin and its clinical applicability in Wilson disease 11ª Reunião Científica Sociedade Portuguesa de Medicina Laboratorial.
Sociedade Portuguesa de Medicina Laboratorial (Coimbra, Portugal)
2018/04/06 tPSA, fPSA, PSA(s) – what we have and how to interpret? 1st Meeting Urology/Primary Care
Hospital of Prelada (Porto, Portugal)
2017/10/18 Excess adiposity and genitourinary cancer 9th Metabolism Symposium, Symposium on Metabolic Syndrome: focus on cardiovascular disease and cancer
Biochemistry Unit, Department of Biomedicine, Faculty of Medicine, University of Porto (Porto, Portugal)
2017/09/24 Personalized urology: personalized medicine in urological oncology National Congress of the Portuguese Association of Urology 2017
Portuguese Association of Urology (Porto, Portugal)
2016/11/20 Precision Medicine in Uro-oncology Academy of Urology, VIth Module
Portuguese Urological Association (Batalha, Portugal)
2016/07/01 Molecular and cellular mechanisms involved in the association between obesity and cancer 7º Workshop de Clinical Biochemistry
Portuguese Society for Clinical Biochemistry and Faculty of Pharmacy, University of Porto (Porto, Portugal)
2016/06/04 Molecular targeting of obesity pathways in cancer European Obesity Summit 2016
EASO and IFSO-EC (Gothenburg, Suécia)
2010/05/29 Técnicas (limites e alcances) e caracterização dos alvos moleculares em oncologia CONCOR&D, Conferência Oncologia R&D
Pfizer Oncology (Porto Salvo, Portugal)

Orientação

Título / Tema
Papel desempenhado 		Curso (Tipo)
Instituição / Organização
2020 - Atual Perirenal adipocytes fueling renal carcinoma: metabolic symbiosis with macrophages and cancer cells at the tumour microenvironment invasive front?
Orientador
 Metabolism – Clinical and Experimental (Doutoramento)
Universidade do Porto Faculdade de Medicina, Portugal
2019/09 - Atual Extracellular-Vesicle based liquid biopsy in bladder cancer: establishing a protocol for the detection of urothelial carcinoma-derived EVs in the urine
Coorientador
 MSc in Oncology (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2018/05 - Atual Urinary Extracellular Vesicles as a source of Biomarkers for Urothelial Cancer
Orientador de Manuel Antonielo Oliveira
 PhD in Medical Sciences (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2018/01 - Atual Correlation between pelvic anatomy on magnetic resonance imaging and urinary continence after radical prostatectomy
Coorientador
 PhD in Medical Sciences (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2017/09 - Atual Peripheral biomarkers in patients with prostate cancer submitted to surgery with curative intent
Coorientador
 PhD in Medical Sciences (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2017/07 - Atual Tumor microenvironment in lymphoma: unraveling adipose tissue’s role in disease aggressiveness
Orientador
 PhD in Biomedical Sciences (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2016/08 - Atual The role of the renin-angiotensin-aldosterone system and hypoxia in lung cancer progression
Coorientador
 PhD in Clinical & Experimental Pharmacology & Toxicology (Doutoramento)
Universidade do Porto Faculdade de Medicina, Portugal
2014/09 - Atual Association between obesity and renal cell cancer: epidemiological, molecular and cellular mechanisms
Coorientador
 PhD in Medical Sciencies (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2022 - 2025 Curb obesity: molecular mechanisms predictive of response to bariatric surgery
Orientador
 PhD in Molecular & Cellular Biology, (Doutoramento)
2019 - 2022 Innovative electrochemical multiplex biosensor for detection and quantification of clinically relevant circulating miRNAs
Coorientador
 Post-Doc Marie Sklodowska Curie Fellowship (Outra)
Universiteit Antwerpen, Bélgica
2017/09 - 2018/06 Study of a Germline Variant in Lymphotoxin Alpha (LTA) Gene in Colorectal Cancer
Coorientador
 MSc in Biotechnology for the Health Sciences (Mestrado)
Universidade de Trás-os-Montes e Alto Douro, Portugal
2014/09 - 2018/03 Identification and characterization of glycobiomarkers in bladder cancer stem cells
Coorientador
 PhD in Pathology and Molecular Genetics (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2015/01 - 2017/12 Does habitual physical activity mitigates chemotherapy-induced cardiac and brain dysfunction in a mouse model of prostate cancer? Role for mitochondrial-mediated mechanisms
Coorientador
 Postdoc FCT Fellow (Outra)
Universidade do Porto Faculdade de Desporto, Portugal
2013 - 2015 Genetic, molecular and cellular determinants of the causal association between obesity and Hodgkin lymphoma
Coorientador
 Master in Metabolic Diseases and Eating Disorders (Mestrado)
Universidade de Lisboa Faculdade de Medicina, Portugal
2009/09 - 2010/07 Adiponectin and tumoral necrosis factor alpha in Multiple Myeloma development
Coorientador
 Master in Oncology (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2008/08 - 2009/07 Primary cultures of human adipose tissue and its impact in prostate cancer
Coorientador
 Master in Molecular and Cellular Biology (Mestrado)
Universidade de Aveiro Departamento de Biologia, Portugal
2008/07 - 2009/07 Genetic variability of LEPR: Molecular epidemiology and functional studies in prostate cancer
Coorientador
 Master in Biology (Mestrado)
Universidade do Porto Faculdade de Ciências, Portugal

Júri de grau académico

Tema
Tipo de participação 		Nome do candidato (Tipo de grau)
Instituição / Organização
2023/07/06 Metabolic and oxidative stress biomarkers associated with male hypogonadism
Arguente principal
 Catarina Filipa Marques Freitas (Outro)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2023/06/12 “The effect of radiopharmaceuticals on the human gut microbiota”. Ana Rita Oliveira Fernandes, , Faculty of Medicine - University of Porto, 12th June 2023.
Arguente
 Ana Rita Oliveira Fernandes (Doutoramento)
Universidade do Porto Faculdade de Medicina, Portugal
2023/03/29 Perfil genético de moduladores de metabolismo ósseo e imunidade na metastização óssea do cancro da próstata resistente à castração
Orientador
 Matthew Salvador Janeiro (Outro)
Universidade de Lisboa Faculdade de Ciências, Portugal
2019/12/04 Genomic Characterization of the Prostaglandin E2 Pathway in Gastric Cancer Development: An Opportunity for Personalized Screening?
Arguente principal
 Catarina Filipa Pereira Lopes (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2019/11/09 The Interplay Between Adipose Tissue and Renal Cell Carcinoma: Decoding the Obesity Paradox
Orientador
 Miguel Mendes Ferreira (Mestrado)
Universidade do Porto Faculdade de Ciências, Portugal
2019/01/09 Epstein-Barr virus and development of posttransplant lymphoproliferative disease in hematopoietic stem cell transplant recipients: Viral activity and host susceptibility
Vogal
 Joana Marinho-Dias (Doutoramento)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2017/05/04 Physical exercise and white adipose tissue plasticity in the context of obesity
Arguente principal
 Silvia Rodrigues (Doutoramento)
Universidade do Porto Faculdade de Desporto, Portugal
2015/12/22 Study of modifier genes in polycistic kidney disease associated with cardiovascular disease”, , , Faculty of Sciences, University of Lisboa, 22nd December 2015.
Arguente principal
 Ana Carolina Santos (Mestrado)
Universidade de Lisboa Faculdade de Ciências, Portugal
2014/12/10 Glyco-profilling of bladder cancer stem cells based on chemotherapy sorting approach”, , , Abel Salazar Biomedical Sciences Institute, University of Porto, 10th december 2014.
Arguente principal
 Beatriz Simão Parreira (Mestrado)
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal

Arbitragem científica em conferência

Nome da conferência Local da conferência
2019/09/10 - 2019/09/14 Oncofit - Exercise and Cancer Symposium Dept. of Oncology, Centro Hospitalar Vila Nova Gaia/Espinho
2017/05/17 - 2017/05/20 24th European Congress on Obesity, ECO2017 European Association for the Study of Obesity
2017/03/22 - 2017/03/25 7th ECTOH - Congress on Tobacco and Health Association of European Cancer Leagues
2016/06/01 - 2016/06/04 European Obesity Summit European Association for the Study of Obesity

Comissão de avaliação

Descrição da atividade
Tipo de assessoria 		Instituição / Organização Entidade financiadora
2013 - 2013 Member of the International Experts Panel for Evaluation of Grant proposals
Especialista
 Cancéropôle du Grand Ouest, França CANCEROPOLE Grand Ouest Program
2012 - 2012 Expert External Assessor for Evaluation of Grant proposals
Especialista
 Prostate Cancer Foundation of Australia, Austrália Prostate Cancer Foundation of Australia
2011 - 2011 Expert External Assessor of the Pluridisciplinary Projects – 2011, Program of Research Initiation Universidade do Porto, Portugal Universidade do Porto

Curso / Disciplina lecionado

Disciplina Curso (Tipo) Instituição / Organização
2018/06 - Atual . PhD Program in Sports Sciences, University Institute of Maia, Portugal (2018 - ). PhD Program in Sports Sciences (Doutoramento) Maiêutica Cooperativa de Ensino Superior CRL, Portugal

Entrevista (jornal / revista)

Descrição da atividade Jornal / Forum
2016 Interview on the obesity paradox in kidney cancer in a feature story entitled “Obesity: the fat advantage” Nature Outlook Kidney Cancer. Nature 2016; 537 (7620): S100-S102.
2013/04/08 Cronical of the Portuguese Cancer League, entitled “Alimentação e cancro”, pp74 VIP Magazine
2012/09/30 Interview about research findings on obesity and prostate cancer Jornal de Notícias
2012/09/26 Interview about our results on periprostatic fat profiling published in BMC Medicine. The Toronto Star journal (Canada)
2012/09/26 Interview to speak about our results published in BMCMedicine, concerning adiposity and prostate cancer VEJA Magazine (Brazil)

Entrevista / Programa (rádio / tv)

Programa Tema
2012/10/26 - Atual “Consultório”, PortoCanal (Portugal) obesity and cancer
2012/09/25 - Atual SIC Noticias Obesity and prostate cancer

Membro de associação

Nome da associação Tipo de participação
2021/06 - Atual Sociedad Iberica de Citometria member
2020 - Atual Portuguese Society of Clinical Pathology member
2017/01 - Atual Sociedad Española de Medicina Laboratorial Resident Member
2017/01 - Atual Portuguese Society for Infeccious Diseases and Clinical Microbiology Associate Member
2017/01 - Atual Portuguese Society of Laboratory Medicine Affiliate Member
2014/01 - Atual International Society of Exercise and Immunology Member
2012/07 - Atual Portuguese Medical Association Affiliate
2010/10 - Atual Association of the Union for International Cancer Control Fellows Life Member
2004 - 2013 European Association for Cancer Research Member
2009 - 2012 Portuguese Society for the Study of Obesity Member
2001 - 2008 American College of Sports Medicine Member
2002 - 2007 New York Academy of Sciences Member
2002 - 2003 American Association for the Advancement of Science Member
Distinções

Prémio

2023 Sable Systems poster presentation award.
2021 1st Prize to the Best Research presented at the 9th Congress of Pandemics at a time of Globalization
Centro Hospitalar e Universitário de Coimbra EPE, Portugal
2021 Distinguished Best ePoster at IJUP 2021
Universidade do Porto, Portugal
2020 Pfizer Grants4targets
2020 24th PROGRAM “EDUCATION BY SCIENCE” (2020/2021)
Universidade de Lisboa Faculdade de Medicina, Portugal
2019 2nd Prize Thomé Villar/Boehringer Ingelheim 2019
Sociedade Portuguesa de Pneumologia, Portugal
2019 Prize SPP/Medinfar 2019 – Best oral communication
Sociedade Portuguesa de Pneumologia, Portugal
2018 Prize Robalo Cordeiro SPP/Novartis 2018
Sociedade Portuguesa de Pneumologia, Portugal
2014 1st Prize Best Oral Communication
Sociedade Portuguesa para o Estudo da Obesidade, Portugal
2013 RayBiotech 2013 Innovative Research Grant Award
2013 Research Grant Award FARMOZ Urology 2013
Associação Portuguesa de Urologia, Portugal
2011 Prize Professor Alexandre Moreira, Research in Sexual Medicine 2011
Associação Portuguesa de Andrologia, Portugal
2010 Research Grant Award Astrazeneca Foundation 2010
Program for Research Support from Astrazeneca Foundation, Portugal
2009 Research Grant Award SPO / SPS / Schering-Plough 2009 – Breast Cancer
Sociedade Portuguesa de Senologia, Portugal

Sociedade Portuguesa de Oncologia, Portugal
2008 Research Grant Award Astrazeneca Foundation 2008
Program for Research Support from Astrazeneca Foundation, Portugal
2008 Research Grant Award APU 2008, Menção Honrosa
Associação Portuguesa de Urologia, Portugal
2006 1st Prize Best Poster, XI National Congress of Pathology
International Academy of Pathology - Portuguese Division, Portugal
2004 1st Prize, Prize Silva Araújo 2004
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal

Centro Hospitalar Universitário do Porto EPE, Portugal
2003 3rd Prize, Prize Silva Araújo 2003
Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal

Centro Hospitalar Universitário do Porto EPE, Portugal
2003 1st Prize, Prize TECNIFAR Headaches 2002
Sociedade Portuguesa de Cefaleias, Portugal
2002 Honour Mention, Prize NOVARTIS Neurology 2002
Sociedade Portuguesa de Neurologia, Portugal

Outra distinção

2014 Research Fellowship, Portuguese League Against Cancer
Liga Portuguesa Contra o Cancro Núcleo Regional do Norte, Portugal
2013 Paper Nominated for the Cancer Category Research Award
2013 Research fellowship, Portuguese League Against Cancer
Liga Portuguesa Contra o Cancro Núcleo Regional do Norte, Portugal
2012 Research fellowship, Portuguese League Against Cancer
Liga Portuguesa Contra o Cancro Núcleo Regional do Norte, Portugal
2010 UICC International Cancer Technology Transfer Fellowship (ICR/10/079/2010)
Union for International Cancer Control (UICC), Suiça
2006 PhD fellowship (SFRH/BD/30021/2006)
Fundação para a Ciência e a Tecnologia, Portugal